Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 90
  • 14
  • 168
  • 694
  • 444
  • 14
  • 31
  • 1
  • 4
  • 646

Found 696 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Study to Evaluate the Safety and Efficacy of Upadacitinib in Giant Cell Arteritis: SELECT-GCA
50 years - 100 years
All genders
Phase 3
The main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug called upadacitinib. Upadacitinib is being tested to find out if it is safe and effective in treating GCA. An investigational drug is one that is …
 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
1 years - 100 years
All genders
Phase 3
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)
18 years - 80 years
All genders
Phase 3
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney disease produces abnormal amounts of a protein called IgA in the kidney that damage the filtering units or glomeruli. Glomeruli are tiny filtering units in the kidney that remove excess …
 The PATCH trial for Healthcare Workers (Prevention and Treatment of COVID-19 with hydroxychloroquine)
18 years - 95 years
All genders
The PATCH trial tests hydroxychloroquine as a treatment in patients with COVID-19 and a preventative medication in health care workers at high risk of contracting COVID-19. 
 The PATCH trial for patients Quarantined at Home (Prevention and Treatment of COVID-19 with hydroxychloroquine)
18 years - 95 years
All genders
A double-blind placebo controlled trial of high dose hydroxychloroquine (HCQ) as a treatment for COVID-19 positive patients who are quarantined at home
18 years - 85 years
All genders
Phase 1
Test Comment here..
 A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia
100 years or below
All genders
The purpose of this research is to test an experimental drug CVL-562 as a possible treatment for early-course schizophrenia, schizoaffective disorder or related psychotic disorder.This study will test whether CVL-562 can help thinking and memory in people with schizophrenia.
 EFFICACY AND SAFETY OF A ONCE-WEEKLY INJECTABLE MEDICINE IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY. (REDEFINE 1)
J
James David
18 years - 100 years
All genders
Phase 1
This study has 2 parts: The first part is the main study and the second part is the extension study. During the main study participants will receive 1 of 4 study medicines. If participants continue in the extension study, they will not receive any study medicine during the extension. The …
 DEPRESSION STUDY: INVESTIGATING LINKS BETWEEN SLEEP AND MOOD
25 years - 50 years
Female
GOAL: This research study aims to examine the role of slow-wave sleep activity in improving mood in individuals with Major Depressive Disorder (MDD).TARGET POPULATION: We are looking for 40 currently depressed males and females and 20 healthy controls with no history of depression between the ages of 25-50. Participants must …
 A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study
18 years - 99 years
Female
The purpose of this study is to: assess if the iVAS can help improve blood circulation, gain a better understanding of how this device could impact your health, determine human interaction with the device, and assess the portability of this device.